Study of the Levels of Immunoglobulin G and Complement 3 in Gestational Diabetes and Their Newborn

Background: The most typical metabolic issue related to pregnancy is gestational diabetes. Because it eliminates undesired germs and causes inflammation, the complement system (C3) is an essential part of the cellular immune system. It has been linked to metabolic diseases, including diabetes, obesity, dyslipidemia, insulin resistance, and liver dysfunction. C3 is also becoming more well recognized as a risk factor for cardiovascular and metabolic diseases. Immunoglobulin levels in maternal blood and colostrum are decreased by hyperglycemia, which also affects IgG transfer across the placenta. Aim of study: to compare the levels of C3 and immunoglobulin G in the sera of pregnant women with gestational diabetes and their babies to pregnant women without the disease. Methods: a case control study that was carried out over the course of four months, from August 18 to December 20, 2020, at the department of obstetrics and gynecology at Salahaddin General Hospital/Salahaddin. It involved 92 pregnant women who separated into two groups and went to the delivery room to deliver a viable fetus: 47 pregnant women in the case group had been diagnosed with gestational diabetes mellitus, whereas the 45 pregnant women in the control group had no complaints and were matched with the other groups' ages and gestational ages. Results for C3 and IgG levels in maternal and cord blood were noted. Results: In this study, the case group's mean birthweight and maternal serum C3 levels were both considerably greater than those of the controls. The mean cord serum IgG level in the case group was substantially lower than that in the controls. Conclusion: Understanding the underlying chronic inflammation that affects the developing fetus' innate immune system and predisposes the person to future diabetes and its consequences may be possible with complement C3 estimate in GDM.

• Publication year

  2023

• Venue

  International Journal of Medical Science and Clinical Research Studies

• Publication date

  2023-09-28

• Fields of study

  Not labeled

• Identifiers
  DOI 10.47191/ijmscrs/v3-i9-47
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications

  2020cited by this paper
• Diabetes and Metabolism

  2020cited by this paper
• Are gestational and type II diabetes mellitus associated with the Apgar scores of full-term neonates?

  2018cited by this paper
• The Pathophysiology of Gestational Diabetes Mellitus

  2018cited by this paper
• Genetic variation of IRA1 gene in women with gestational diabetes mellitus in Iraq in third trimester stage

  2018cited by this paper
• Maternal and fetal outcome in gestational diabetic women

  2018cited by this paper
• Neonatal Glycemic Status of Infants of Diabetic Mothers in a Tertiary Care Hospital

  2018cited by this paper
• Gestational Diabetes Mellitus and Hormonal Alteration

  2017cited by this paper
• Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective

  2016cited by this paper
• [Gestational Diabetes].

  2016cited by this paper
• Is There a Role for HbA1c in Pregnancy?

  2016cited by this paper
• Chinese Herbal Products for Female Infertility in Taiwan

  2016cited by this paper
• Impact of maternal diabetes mellitus on mortality and morbidity of very low birth weight infants: a multicenter Latin America study.

  2015cited by this paper
• A Study of Complement C3 and Immunoglobulin G levels in Gestational Diabetics and their Newborns

  2015cited by this paper
• Gestational Diabetes Mellitus and Macrosomia: A Literature Review

  2015cited by this paper
• Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG3)

  2015cited by this paper
• Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period (NG 3)

  2015cited by this paper
• High risk of neonatal complications in children of mothers with gestational diabetes mellitus in their first pregnancy.

  2015cited by this paper
• IgG Subclasses and Allotypes: From Structure to Effector Functions

  2014cited by this paper
• Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study

  2014cited by this paper
• Gestational diabetes mellitus.

  2013cited by this paper
• The effect of diet on pregnancy outcomes among pregnant with abnormal glucose challenge test.

  2013cited by this paper
• Transfer of Maternal Immunity to Newborns of Diabetic Mothers

  2012cited by this paper
• Complement C3: an emerging risk factor in cardiometabolic disease

  2012cited by this paper
• IgG Placental Transfer in Healthy and Pathological Pregnancies

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Risk factors for gestational diabetes mellitus: Implications for the application of screening guidelines

  2011cited by this paper
• Pathophysiology of Gestational Diabetes Mellitus: The Past, the Present and the Future

  2011cited by this paper
• Complement mediated bactericidal activity and humoral immune response in type 2 diabetes mellitus

  2006cited by this paper
• Controversies around gestational diabetes. Practical information for family doctors.

  2005cited by this paper
• Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

  2005cited by this paper
• Complement C 3 Is a Risk Factor for the Development of Diabetes A Population-Based Cohort Study

  2005cited by this paper
• Effects of diabetic pregnancy on the fetus and newborn.

  2000cited by this paper
• Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.

  1999cited by this paper
• IgG subclasses.

  1992cited by this paper
• [Serum immunoglobulins in diabetic and healthy pregnant patients and their newborn infants].

  1984cited by this paper

• No citing papers are available for this paper.